TwitterLinkedInYoutubeSlideshareflickrIFPMA - Global Health Matters - BlogRSS
IFPMA Home

International Federation of Pharmaceutical Manufacturers & Associations



Filters
<< FirstLast >>

United Nations NCD Review – Roundtable 2: “Fostering and strengthening national, regional and international partnerships and cooperation in support of efforts to address non-communicable diseases - NCDs”

11 July 2014

IFPMA Statement, WHA 67, Item 16.5, Combating antimicrobial resistance, including antibiotic resistance

24 May 2014

IFPMA Statement under WHA 67 agenda item 15.6 Regulatory system strengthening (resolution EB134.R19) Access to biotherapeutic products and ensuring quality, safety and efficacy

23 May 2014

IFPMA Statement under WHA 67, Check against delivery – Item 13.3 Prevention and Control of Non Communicable Diseases, NCD Global Coordination Mechanism

22 May 2014

IFPMA Statement under WHA 67 agenda item 11.3, Framework of engagement with non-State actors

20 May 2014

IFPMA Statement at mhGAP Forum, Geneva, October 7, 2013

10 October 2013

IFPMA Statement, EB 133, Item 6.2, Psoriasis

30 May 2013

IFPMA Statement under agenda item 5, "WHO Reform"

30 May 2013

IFPMA Statement under WHA 66 agenda item 13.2 on Draft action plan for the prevention and control of noncommunicable diseases 2013–2020

27 May 2013

IFPMA Statement, WHA 66, Item 16.2, Neglected tropical diseases

25 May 2013

IFPMA statement under WHA 66 agenda item 16.1 on Global Vaccine Action Plan (GVAP)

24 May 2013

IFPMA Statement, WHA 66, Item 17.2, Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination

24 May 2013

Filters
<< FirstLast >>
Filters
<< FirstLast >>

11 July 2014,

United Nations NCD Review – Roundtable 2: “Fostering and strengthening national, regional and international partnerships and cooperation in support of efforts to address non-communicable diseases - NCDs”

Category: Statements

Details

24 May 2014,

IFPMA Statement, WHA 67, Item 16.5, Combating antimicrobial resistance, including antibiotic resistance

Category: Statements

Details

23 May 2014,

IFPMA Statement under WHA 67 agenda item 15.6 Regulatory system strengthening (resolution EB134.R19) Access to biotherapeutic products and ensuring quality, safety and efficacy

Category: Statements

Details

22 May 2014,

IFPMA Statement under WHA 67, Check against delivery – Item 13.3 Prevention and Control of Non Communicable Diseases, NCD Global Coordination Mechanism

Category: Statements

Details

20 May 2014,

IFPMA Statement under WHA 67 agenda item 11.3, Framework of engagement with non-State actors

Category: Statements

Details

10 October 2013,

IFPMA Statement at mhGAP Forum, Geneva, October 7, 2013

Details

30 May 2013,

IFPMA Statement, EB 133, Item 6.2, Psoriasis

Category: Global Health

Details

30 May 2013,

IFPMA Statement under agenda item 5, "WHO Reform"

Details

27 May 2013,

IFPMA Statement under WHA 66 agenda item 13.2 on Draft action plan for the prevention and control of noncommunicable diseases 2013–2020

Details

25 May 2013,

IFPMA Statement, WHA 66, Item 16.2, Neglected tropical diseases

Category: Global Health

Details

24 May 2013,

IFPMA statement under WHA 66 agenda item 16.1 on Global Vaccine Action Plan (GVAP)

Category: Global Health

Details

24 May 2013,

IFPMA Statement, WHA 66, Item 17.2, Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination

Details
Filters
<< FirstLast >>